Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13
Bajic, Vladimir B.
Choolani, Mahesh A.
KAUST DepartmentComputational Bioscience Research Center (CBRC)
Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division
Applied Mathematics and Computational Science Program
Online Publication Date2013-02-01
Print Publication Date2013-03
Permanent link to this recordhttp://hdl.handle.net/10754/562647
MetadataShow full item record
AbstractObjectives: To use proteomics to identify and characterize proteins in maternal serum from patients at high-risk for fetal trisomy 21, trisomy 18, and trisomy 13 on the basis of ultrasound and maternal serum triple tests. Methods: We performed a comprehensive proteomic analysis on 23 trisomy cases and 85 normal cases during the early second trimester of pregnancy. Protein profiling along with conventional sodium dodecyl sulfate polyacrylamide gel electrophoresis/Tandem mass spectrometry analysis was carried out to characterize proteins associated with each trisomy condition and later validated using Western blot. Results: Protein profiling approach using surface enhanced laser desorption/ionization time-of-flight mass (SELDI-TOF/MS) spectrometry resulted in the identification of 37 unique hydrophobic proteomic features for three trisomy conditions. Using sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by Matrix Assisted Laser Desorption Ionization - Time of Flight/Time of Flight (MALDI-TOF/TOF) and western blot, glyco proteins such as alpha-1-antitrypsin, apolipoprotein E, apolipoprotein H, and serum carrier protein transthyretin were identified as potential maternal serum markers for fetal trisomy condition. The identified proteins showed differential expression at the subunit level. Conclusions: Maternal serum protein profiling using proteomics may allow non-invasive diagnostic testing for the most common trisomies and may complement ultrasound-based methods to more accurately determine pregnancies with fetal aneuploidies. © 2013 John Wiley & Sons, Ltd.
SponsorsThis work was supported by the National Medical Research Council (NMRC), Singapore (Grant number: R173-000-071-213) and the Biomedical Research Council (BMRC) Singapore (Grant number: R174-000-091-305) for providing funds to carry out this project.
- Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
- Authors: Revello R, Sarno L, Ispas A, Akolekar R, Nicolaides KH
- Issue date: 2016 Jun
- Prenatal screening for fetal aneuploidy in singleton pregnancies.
- Authors: Chitayat D, Langlois S, Douglas Wilson R, SOGC GENETICS COMMITTEE., CCMG PRENATAL DIAGNOSIS COMMITTEE.
- Issue date: 2011 Jul
- Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.
- Authors: Hsu TY, Lin H, Hung HN, Yang KD, Ou CY, Tsai CC, Cheng HH, Chung SH, Cheng BH, Wong YH, Chou AK, Hsiao CC
- Issue date: 2016
- Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
- Authors: Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, Chan HY, Chan WS, Choy KW
- Issue date: 2014 Mar
- Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
- Authors: Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH
- Issue date: 2016 Jan